A carregar...
The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival
Glioblastoma (GBM) is resistant to multimodality therapeutic approaches. A high burden of tumor-specific mutant peptides (neoantigens) correlates with better survival and response to immunotherapies in selected solid tumors but how neoantigens impact clinical outcome in GBM remains unclear. Here, we...
Na minha lista:
| Publicado no: | Commun Biol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478916/ https://ncbi.nlm.nih.gov/pubmed/31044160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0369-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|